{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-062116","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2024-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.264185+00:00","generated_at":"2026-06-01T12:15:43.725553+00:00","sec_items":["5.08","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Plus Therapeutics sets 2024 annual meeting for August 15; stockholder proposals due May 30","bullets":["Annual meeting to be held virtually on August 15, 2024 at 9:00 a.m. Eastern Time.","Record date for stockholders entitled to vote is June 25, 2024.","Stockholder proposals and director nominations must be received by May 30, 2024 at 5:00 p.m. ET."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-062116","json":"https://secwatch.observer/filing/0000950170-24-062116.json","markdown":"https://secwatch.observer/filing/0000950170-24-062116.md","text":"https://secwatch.observer/filing/0000950170-24-062116.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000095017024062116/0000950170-24-062116-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000095017024062116/pstv-20240516.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T12:15:43.725553+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}